PRMT1 Inhibition Promotes Ferroptosis Sensitivity via ACSL1 Upregulation in Acute Myeloid Leukemia

The authors identified protein arginine methyltransferase 1 (PRMT1) as a ferroptosis regulator in AML. The type I PRMT inhibitor GSK3368715 promoted ferroptosis sensitivity in vitro and in vivo.